You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Ranitidine administered intravenously or orally during labor and Cesarean sections did not negatively impact maternal or neonatal outcomes. Fetal exposure to ranitidine was minimal, with low levels observed in newborns post-delivery.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: